SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-025853
Filing Date
2024-08-09
Accepted
2024-08-09 16:03:55
Documents
72
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tgtx20240630_10q.htm   iXBRL 10-Q 1647165
2 EXHIBIT 10.2 ex_711621.htm EX-10.2 1069071
3 EXHIBIT 31.1 ex_678351.htm EX-31.1 12338
4 EXHIBIT 31.2 ex_678352.htm EX-31.2 12682
5 EXHIBIT 32.1 ex_678353.htm EX-32.1 5747
6 EXHIBIT 32.2 ex_678354.htm EX-32.2 6064
  Complete submission text file 0001437749-24-025853.txt   8237641

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA tgtx-20240630.xsd EX-101.SCH 61168
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tgtx-20240630_cal.xml EX-101.CAL 42216
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tgtx-20240630_def.xml EX-101.DEF 432996
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE tgtx-20240630_lab.xml EX-101.LAB 368838
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tgtx-20240630_pre.xml EX-101.PRE 461170
75 EXTRACTED XBRL INSTANCE DOCUMENT tgtx20240630_10q_htm.xml XML 906420
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32639 | Film No.: 241192503
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)